Concord Drugs Ltd — Insider Trading, 26-09-2025: Insider Trading / SAST

Concord Drugs Limited has announced the closure of its trading window for company securities. This closure will begin from October 1st and remain in effect until 48 hours after the financial results for the quarter ending September 30th are declared. During this period, Directors, Designated Employees, Insiders, and their immediate relatives are prohibited from trading the company's securities. This measure ensures fair and transparent dealing ahead of the financial results. The company will separately announce the date of its Board Meeting to consider and approve these results.